Prostate Cancer - Results from #21640

The percentage of core involved by cancer is the best predictor of insignificant prostate cancer, according to an updated definition (tumor volume up to 2.5 cm(3)): Analysis of a cohort of 210 consecutive patients with low-risk disease - Abstract December 19, 2013

Bone mineral density in prostate cancer: A comparative study of patients with prostate cancer and healthy controls using propensity score matching - Abstract December 19, 2013

Differences in upgrading of prostate cancer in prostatectomies between community and academic practices - Abstract December 19, 2013

Intensity-modulated radiation therapy (IMRT) for localized and locally advanced prostate cancer: Initial result and morbidity - Abstract December 18, 2013

The expanding role of MRI in prostate cancer - Abstract December 18, 2013

A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The PROFUS trial - Abstract December 18, 2013

Removal of limited nodal disease in patients undergoing radical prostatectomy: Long-term results confirm a chance for cure - Abstract December 18, 2013

'Race' and prostate cancer mortality in equal-access healthcare systems - Abstract December 18, 2013

Prevalence and factors associated with conducting screening tests for prostate cancer in the elderly in Juiz de Fora in the state of Minas Gerais, Brazil - Abstract December 18, 2013

The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy - Abstract December 18, 2013

Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects - Abstract December 18, 2013

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator? - Abstract December 18, 2013

Prostate-specific antigen kinetics parameters are predictive of positron emission tomography features worsening in patients with biochemical relapse after prostate cancer treatment with radical intent: Results from a longitudinal cohort study - Abstract December 18, 2013

Diethylstilboestrol for the treatment of prostate cancer: Past, present and future - Abstract December 18, 2013

Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients - Abstract December 18, 2013

High percent tumor volume predicts biochemical recurrence after radical prostatectomy in pathological stage T3a prostate cancer with a negative surgical margin - Abstract December 18, 2013

Robotic ultrasound and needle guidance for prostate cancer management: Review of the contemporary literature - Abstract December 18, 2013

Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases - Abstract December 18, 2013

Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: Retrospective analysis of a single institution experience - Abstract December 18, 2013

Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate - Abstract December 18, 2013

Page 1083 of 1438